SFDA Chief Spearheads Saudi Presence At Global Medical Device Forum

The CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Al-Jadhey, recently led the Kingdom's delegation at the 25th annual meeting of the International Medical Device Regulators Forum (IMDRF) in Washington, from March 11-15. This significant event brought together regulators from across the globe, including the European Union, United States, United Kingdom, Australia, Canada, and Japan, alongside representatives from leading industry companies. The discussions focused on a variety of critical topics concerning the regulation and oversight of medical devices.

Among the primary subjects addressed were the importance of post-marketing accreditation, the latest regulatory updates, and the progress of regional working groups and coordination initiatives. These discussions underscored the ongoing efforts to enhance global collaboration in ensuring the safety and efficacy of medical devices.

During this prestigious gathering, Dr. Al-Jadhey had the opportunity to meet with Dr. Robert Califf, Commissioner of the U.S. Food and Drug Administration (FDA). Their conversation revolved around strengthening strategic cooperation between the SFDA and U.S. FDA. They explored avenues to enhance collaboration in medical device regulation and safety oversight, highlighting the vital role international forums play in capacity building, information sharing, and close coordination.

Additionally, Dr. Al-Jadhey engaged in talks with Dr. Rajeev Singh Raghuvanshi, Drugs Controller General of India and CEO of the Central Drugs Standard Control Organization (CDSCO) of India. Their discussion focused on topics of mutual interest, particularly issues related to pharmaceutical and medical device industries.

The participation of Saudi Arabia's delegation in the IMDRF meeting is a testament to the Kingdom's commitment to playing an active role in global health regulation. By engaging in dialogue with international counterparts and industry leaders, Saudi Arabia aims to ensure that its regulatory practices for medical devices remain aligned with global standards. This not only facilitates international trade but also ensures that medical devices available in the Saudi market meet high safety and efficacy standards.

The meetings with representatives from both the U.S. FDA and CDSCO further highlight Saudi Arabia's dedication to fostering international cooperation. By discussing ways to boost strategic partnerships and sharing best practices, SFDA is working towards enhancing its regulatory framework for the benefit of public health both domestically and globally.

This engagement at an international level is crucial for keeping abreast of the latest developments in medical device regulation. It enables countries like Saudi Arabia to adopt innovative approaches to regulatory oversight, ensuring that their healthcare systems benefit from access to safe and effective medical technologies.

The outcomes of these discussions are expected to contribute significantly to advancing global health security through improved regulation and oversight of medical devices. As such meetings continue to facilitate open dialogue among international regulators and industry stakeholders, they serve as a cornerstone for collaborative efforts aimed at enhancing public health outcomes worldwide.

With inputs from SPA